Direct control of CAR T cells through small molecule-regulated antibodies
Many next-generation antibody therapeutics have enhanced potency but the risk of adverse events. Here the authors develop a conditionally activated, single-module CAR.
Bibliographic Details
| Main Authors: |
Spencer Park,
Edward Pascua,
Kevin C. Lindquist,
Christopher Kimberlin,
Xiaodi Deng,
Yvonne S. L. Mak,
Zea Melton,
Theodore O. Johnson,
Regina Lin,
Bijan Boldajipour,
Robert T. Abraham,
Jaume Pons,
Barbra Johnson Sasu,
Thomas J. Van Blarcom,
Javier Chaparro-Riggers |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Nature Portfolio
2021-01-01
|
|---|
| Series: | Nature Communications
|
|---|
| Online Access: | https://doi.org/10.1038/s41467-020-20671-6
|
|---|